Search

News type
1918 - 1926 of 2102 results

Cold weather

As the weather gets colder and wetter, people with cystic fibrosis may need to take extra care to look after their health.

CF diabetes

Find out more about how CFD (cystic fibrosis diabetes) differs from other types of diabetes, which symptoms to expect and how to help treat it.
Search result from the Trials Tracker

ALPINE 2: AZLI for children with CF and PA lung infection

CTAP badge

The primary objective of this study is to evaluate the safety and efficacy of a 14-day course versus a 28-day course of aztreonam for inhalation solution (AZLI) in participants with new onset Pseudomonas aeruginosa respiratory tract infection.

APLINE2 study published results in 2024. The study did not find that the shorter 14-day course was better or as effective as the longer 28-day course. However, as the shorter course was well tolerated and no new safety concerns were found, this study supports further studies looking at shorter courses of treatment for this age group.

Click below to find out more. Find out more
Trials Tracker ID
TT001696
Age range
Between 3 months and 18 years
Length of participation
28 days
Trial status
Closed with results
Therapeutic approach
Anti-Infective

Legacy Giving Webinar

Gifts in Wills could change what it means to live with CF in the future. Generous gifts have already helped life-changing research, but there is still so much we need to do. Join us at this webinar to find out more about what impact leaving a gift in your will could mean.

Conferences and meetings

Cystic Fibrosis Trust organises conferences and events across the UK. Find out more about how you can get involved.
Search result from the Trials Tracker

CF Tummy Tracker

Tummy symptoms such as bloating, pain and nausea are common for people with cystic fibrosis (CF). These symptoms can be embarrassing and disruptive to everyday life. Despite this, most questionnaires used in CF research are not actually CF-specific. We need to change this. It is important that we have a CF-specific tool so that researchers can understand the daily impact of tummy symptoms for people with CF when it comes to studies, trials, treatments and ongoing care. This will help us address the CF tummy issues that matter most to YOU. Not just the things that clinicians and researchers think...

151 people with CF signed up to test CF Tummy Tracker® in a smartphone app. Nearly all said the questions were clear, relevant and helped them become more aware of their tummy symptoms. Participants said the app was quick to use, simple to navigate, and almost 7 out of 10 said they would use the app again. The full results are available on the CF Tummy Tracker website.

Click below to find out more. Find out more
Trials Tracker ID
TT009111
Age range
Aged 12 years and older
Length of participation
14 days (2 weeks)
Trial status
Recruitment complete
Therapeutic approach
Nutritional-GI
Remote participation
Remote participation is possible for this trial